Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Current Deferred Revenue (2018 - 2025)

Historic Current Deferred Revenue for INVO Fertility (IVF) over the last 8 years, with Q3 2025 value amounting to $720407.0.

  • INVO Fertility's Current Deferred Revenue rose 2809.47% to $720407.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $720407.0, marking a year-over-year increase of 2809.47%. This contributed to the annual value of $602359.0 for FY2024, which is 4735.93% up from last year.
  • INVO Fertility's Current Deferred Revenue amounted to $720407.0 in Q3 2025, which was up 2809.47% from $834850.0 recorded in Q2 2025.
  • Over the past 5 years, INVO Fertility's Current Deferred Revenue peaked at $3.4 million during Q1 2021, and registered a low of $5793.0 during Q1 2022.
  • Its 5-year average for Current Deferred Revenue is $544797.6, with a median of $416745.0 in 2024.
  • The largest annual percentage gain for INVO Fertility's Current Deferred Revenue in the last 5 years was 193179.66% (2022), contrasted with its biggest fall of 9982.93% (2022).
  • Over the past 5 years, INVO Fertility's Current Deferred Revenue (Quarter) stood at $5900.0 in 2021, then skyrocketed by 1931.8% to $119876.0 in 2022, then skyrocketed by 240.99% to $408769.0 in 2023, then surged by 47.36% to $602359.0 in 2024, then rose by 19.6% to $720407.0 in 2025.
  • Its last three reported values are $720407.0 in Q3 2025, $834850.0 for Q2 2025, and $725330.0 during Q1 2025.